These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission. Inada M; Okawa H; Suzuki M; Yata J Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376 [TBL] [Abstract][Full Text] [Related]
4. [Activity of natural killers in acute leukemia in children]. Blinov MN; Vartanian NL; Luganova IS; Klubovskaia NI; Alekseev NA Vopr Onkol; 1988; 34(4):421-5. PubMed ID: 3376454 [TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) activity in children with acute lymphoblastic leukemia. Tanaka Y Hiroshima J Med Sci; 1981 Jun; 30(2):127-33. PubMed ID: 6946050 [No Abstract] [Full Text] [Related]
6. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells. Pattengale PK; Sundstrom C; Yu AL; Levine A Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341 [TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421 [TBL] [Abstract][Full Text] [Related]
8. [Cytotoxic activity of K cells in lymphocytic leukemia]. Górska B; Konopka L; Seyfried H; Pawelski S Acta Haematol Pol; 1981; 12(1):7-15. PubMed ID: 7315149 [No Abstract] [Full Text] [Related]
9. [Natural killer (NK) cell activity in the peripheral blood of patients with malignant diseases: melanoma, carcinoma, chronic and acute lymphatic leukemia]. Gabrilovac J Lijec Vjesn; 1985 Aug; 107(8):323-6. PubMed ID: 3864002 [No Abstract] [Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
11. [Antileukemic cellular immunity characteristics in the immunotherapy of acute lympholeukemia in children]. Bergol'ts VM; Osipov SG; Eremeev VS; Rumiantseva AG; Akimova GV Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):12-4. PubMed ID: 6948291 [No Abstract] [Full Text] [Related]
12. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Moretta A; Locatelli F; Moretta L Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920 [TBL] [Abstract][Full Text] [Related]
13. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells. Xun CQ; Thompson JS; Jennings CD; Brown SA Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742 [TBL] [Abstract][Full Text] [Related]
14. Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia. Gupta S; Fernandes G J Clin Lab Immunol; 1983 Nov; 12(3):155-7. PubMed ID: 6607357 [TBL] [Abstract][Full Text] [Related]